Clinical trial of Qurs e Isqeel in congestive heart failure imtelai as an adjuvant therapy-A double blind study
Not Applicable
- Conditions
- Health Condition 1: I508- Other heart failure
- Registration Number
- CTRI/2021/10/037052
- Lead Sponsor
- Department of Moalejat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of both sexes
Patients diagnosed with heart failure with a reduced ejection fraction.
Exclusion Criteria
Additional co-morbid diseases like of chronic liver and renal diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in ejection fraction of post MI heart failure patientsTimepoint: every 30 days for three months
- Secondary Outcome Measures
Name Time Method Subjective Parameters, breathlessness, chest painTimepoint: every 30 days for three months